Clearmind Shares Promising Real-World Insights from Ongoing CMND-100 First-in-Human Trial
Go back to Clearmind Shares Promising Real-World Insights from Ongoing CMND-100 First-in-Human Trial| (NASDAQ: CMND) | Delayed: 1.83 -0.11 (5.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.94 | 52 Week High | $ | |||
| Open | $1.93 | 52 Week Low | $ | |||
| Day High | $1.93 | P/E | N/A | |||
| Day Low | $1.76 | EPS | $ | |||
| Volume | 221,095 | |||||
